Idexx Laboratories (IDXX) Operating Margin (2009 - 2026)

Idexx Laboratories has reported Operating Margin for 18 years, with the latest figure at 34.98% in Q2 2026.

• On a quarterly basis, Operating Margin rose 136.0% year-over-year to 34.98% in Q2 2026; TTM through Jun 2026 was 32.03%, a 95.0% increase from a year earlier, with the FY2025 full-year figure at 31.6%, up 265.0% from the prior year.
• Operating Margin was 34.98% for Q2 2026 at Idexx Laboratories, up from 31.78% in the prior quarter.
• The five-year high for Operating Margin was 34.98% in Q2 2026, with the low at 20.81% in Q2 2022.
• Average Operating Margin over 5 years is 29.76%, with a median of 30.54% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Margin slumped 1057 bps in 2022, then surged 1058 bps in 2023.
• Over 5 years, Operating Margin stood at 27.34% in 2022, then retreated by 0 bps to 27.21% in 2023, then increased by 1 bps to 27.42% in 2024, then advanced by 6 bps to 28.94% in 2025, then climbed by 21 bps to 34.98% in 2026.
• The last three Operating Margin figures came in at 34.98% (Q2 2026), 31.78% (Q1 2026), and 28.94% (Q4 2025), per Business Quant data.